Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and "Universal" Vaccine Development.

MLA

Memoli, Matthew J., et al. “Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and ‘Universal’ Vaccine Development.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 70, no. 5, Feb. 2020, pp. 748–53. EBSCOhost, https://doi.org/10.1093/cid/ciz281.

APA

Memoli, M. J., Han, A., Walters, K.-A., Czajkowski, L., Reed, S., Athota, R., Angela Rosas, L., Cervantes-Medina, A., Park, J.-K., Morens, D. M., Kash, J. C., & Taubenberger, J. K. (2020). Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and “Universal” Vaccine Development. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 70(5), 748–753. https://doi.org/10.1093/cid/ciz281

Chicago

Memoli, Matthew J, Alison Han, Kathie-Anne Walters, Lindsay Czajkowski, Susan Reed, Rani Athota, Luz Angela Rosas, et al. 2020. “Influenza A Reinfection in Sequential Human Challenge: Implications for Protective Immunity and ‘Universal’ Vaccine Development.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 70 (5): 748–53. doi:10.1093/cid/ciz281.